The translational landscape of mTOR signalling steers cancer initiation and metastasis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature

• Publication date

  2012-02-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature10912PMID 22367541PMCID PMC3663483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vimentin organization modulates the formation of lamellipodia

  2011cited by this paper
• Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblasts.

  2011cited by this paper
• eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

  2010cited by this paper
• mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs

  2010cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• Basal epithelial stem cells are efficient targets for prostate cancer initiation

  2010cited by this paper
• Isolation, cultivation and characterization of adult murine prostate stem cells

  2010cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

  2010cited by this paper
• Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

  2010cited by this paper
• mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.

  2009cited by this paper
• Differential Requirement of mTOR in Postmitotic Tissues and Tumorigenesis

  2009cited by this paper
• A luminal epithelial stem cell that is a cell of origin for prostate cancer

  2009cited by this paper
• Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.

  2009cited by this paper
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

  2009cited by this paper
• Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.

  2009cited by this paper
• Inhibitor Hijacking of Akt Activation

  2009cited by this paper
• Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling

  2009cited by this paper
• MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

  2008cited by this paper
• Generation of a prostate from a single adult stem cell

  2008cited by this paper
• Pilot study of rapamycin in patients with hormone-refractory prostate cancer.

  2008cited by this paper
• Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

  2006cited by this paper
• SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

  2006cited by this paper
• Metastasis‐associated protein 1 enhances stability of hypoxia‐inducible factor‐1α protein by recruiting histone deacetylase 1

  2006cited by this paper
• Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

  2005cited by this paper
• Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

  2005cited by this paper
• Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

  2004cited by this paper
• The Role of Metastasis-Associated Protein 1 in Prostate Cancer Progression

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

  2003cited by this paper
• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

  2002cited by this paper
• Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma

  2002cited by this paper
• Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics*

  2002cited by this paper
• Regulation of translation initiation by FRAP/mTOR.

  2001cited by this paper
• Amino Acid-Induced Translation of TOP mRNAs Is Fully Dependent on Phosphatidylinositol 3-Kinase-Mediated Signaling, Is Partially Inhibited by Rapamycin, and Is Independent of S6K1 and rpS6 Phosphorylation

  2001cited by this paper
• La protein has a positive effect on the translation of TOP mRNAs in vivo.

  2000cited by this paper
• Synthesis of the translational apparatus is regulated at the translational level.

  2000cited by this paper
• Research article

  1999cited by this paper
• 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.

  1998cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• Prognostic factors in localized prostatic carcinoma.

  1985cited by this paper

• A cellular basis for the mammalian nocturnal-diurnal switch.

  2026cites this paper
• A Decade of Innovation in Breast Cancer (2015–2025): A Comprehensive Review of Clinical Trials, Targeted Therapies and Molecular Perspectives

  2026cites this paper
• Impact of Spheroid Use for Identifying Hepatocellular Carcinoma Features: Involvement of Kinase-Mediated Molecular Pathways.

  2026cites this paper
• Environmental Amino Acid Sensing Regulates the Rate of ASC Translation and NLRP3 Inflammasome Assembly

  2026cites this paper
• Hsp90α as a Promising Therapeutic Target for Suppressing Tumor Progression in Lactotroph PitNETs.

  2026cites this paper
• eIF3 musketeers: loyal in health, rogue in disease, and redeemed by therapeutic targeting.

  2026cites this paper
• Exploring the role of mTOR pathway in aging and age-related disorders

  2025cites this paper
• eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by small molecules

  2025cites this paper
• TESMIN promotes lung adenocarcinoma proliferation, migration and invasion via PI3K/AKT/mTOR signaling

  2025cites this paper
• Loss of Kmt2c/d promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapy

  2025cites this paper
• Targeting autophagy kinases: from mechanisms to therapy with novel small molecules.

  2025cites this paper
• HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity

  2025cites this paper
• The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies

  2025cites this paper
• An engineered glioblastoma model yields macrophage-secreted drivers of invasion

  2025cites this paper
• Metabolic Signaling in the Tumor Microenvironment

  2025cites this paper
• Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma

  2025cites this paper
• GLUT3 coordinates mitochondrial respiration and metabolic reprogramming in ERα-positive breast cancer.

  2025cites this paper
• Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.

  2025cites this paper
• SGLT2i delays c-Myc-induced HCC progression via targeting mTOR.

  2025cites this paper
• Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors

  2025cites this paper
• Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes

  2025cites this paper
• Investigation into biased signaling, glycosylation, and drug vulnerability of acute myeloid leukemia.

  2025cites this paper
• eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by novel small molecules

  2025cites this paper
• Eukaryotic translation initiation factor 4F: functional properties and physiological role

  2025cites this paper
• mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery

  2025cites this paper
• GSDME Deficiency Suppresses ER Stress-Induced Autophagic Cell Death via mTOR/S6K1 Activation in Hepatobiliary Carcinomas.

  2025cites this paper
• Multipurpose RNA maturation factors dysregulate multiple mRNA processing steps simultaneously and provide new therapeutic opportunities

  2025cites this paper
• OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression.

  2025cites this paper
• SPIDR enables multiplexed mapping of RNA-protein interactions and uncovers a mechanism for selective translational suppression upon cell stress.

  2025cites this paper
• 4EBP1 phosphorylation mediates TGF-β1-induced hepatic fibrosis and upregulates HIF-1α expression

  2025cites this paper
• RPL5 deficiency-induced ribosomal stress targets a select subset of proteins and inhibits the PI3K-Akt-mTOR signaling pathway to eradicate leukemia stem cells

  2025cites this paper
• Conserved Functions of LARP1 Proteins in Eukaryotes

  2025cites this paper
• Anoikis resistance and cancer

  2025cites this paper
• Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types

  2025cites this paper
• Targeting mTORC1 to promote ferroptosis and apoptosis in endometrial cancer with PI3K-Akt-mTOR pathway mutation

  2025cites this paper
• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia

  2025cites this paper
• High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma

  2025cites this paper
• Alternative 5′UTR Isoforms Drive Enhanced Translational Efficiency via TOP/PRTE Motif Switches in Squamous Cell Carcinoma

  2025cites this paper
• Phosphatidylinositol-4,5-bisphosphate 3-kinase family in GtoPdb v.2025.1

  2025cites this paper
• Evaluating Oncogenic Drivers and Therapeutic Potential of the PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma: An Overview of Clinical Trials

  2025cites this paper
• Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer.

  2025cites this paper
• Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review

  2025cites this paper
• Harnessing the Evolution of Proteostasis Networks to Reverse Cognitive Dysfunction

  2025cites this paper
• The Central FacilitaTOR: Coordinating Transcription and Translation in Eukaryotes

  2025cites this paper
• Targeting protein synthesis pathways in MYC-amplified medulloblastoma

  2025cites this paper
• Phosphatidylinositol kinases in GtoPdb v.2025.1

  2025cites this paper
• Muscle fiber Myc is dispensable for muscle growth and its forced expression severely perturbs homeostasis

  2025cites this paper
• Cardiac Aging: Molecular Mechanisms and Therapeutic Interventions.

  2025cites this paper
• Using SPIDRs to map the RNA-protein web.

  2025cites this paper
• Bioinformatics Approach to mTOR Signaling Pathway-Associated Genes and Cancer Etiopathogenesis

  2025cites this paper
• Rare codon translation regulates growth factor-dependent cell proliferation

  2025cites this paper
• Polysomal profiling coupled to allele-specific proteomics reveals an EIF4H tranSNP allele possessing higher mRNA translation potential

  2025cites this paper
• Spatially Organized IGF1–mTOR Signaling Controls Human Forebrain Progenitor F ate Through Coordinated Transcriptional and Translational Programs

  2025cites this paper
• mTOR blockade mitigates chemotherapy drug-induced intestinal toxicity via inhibition of pyroptosis.

  2025cites this paper
• Cytoskeletal Remodeling by Oncoviruses: A Key Factor in Tumor Invasion and Metastasisa

  2025cites this paper
• An Adipose mTORC1 Effector Links Nutrient-induced Ribosomal Protein Translation to Lifespan in Drosophila

  2025cites this paper
• Insights into noncanonical and diversified functions of ABCF1: from health to disease.

  2025cites this paper
• RLIG1 promotes triple-negative breast cancer proliferation by activating mTORC1 signal pathway by interacting with ERK.

  2025cites this paper
• BCL-2 family inhibition enhances MTORC1/2 inhibition in PIK3CA mutant colorectal cancer.

  2025cites this paper
• CD99 promotes self-renewal in hematopoietic stem cells and leukemia stem cells by regulating protein synthesis

  2025cites this paper
• Coordinated expression of retained introns and poison exons in renal cell carcinoma

  2025cites this paper
• Small molecule inhibitors for treating breast cancer: drug analysis based on the pathogenesis of breast cancer.

  2025cites this paper
• Mg2+ influx mediated by TRPM7 triggers the initiation of muscle stem cell activation

  2025cites this paper
• TOR1 dysfunction promotes phenotypic diversity in the asexual fungus Candida albicans

  2025cites this paper
• Nutrient-driven TOR signalling controls a chromatin-associated complex for orchestrating plant growth and stress tolerance

  2025cites this paper
• Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy

  2025cites this paper
• Aging influences nucleolar responses to traumatic brain injury in Drosophila

  2025cites this paper
• Bioinformatic Investigation of Regulatory Elements in the Core Promoters of CK2 Genes and Pseudogene

  2025cites this paper
• Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory

  2025cites this paper
• mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism

  2024cites this paper
• Muscle fiber Myc is dispensable for muscle growth and forced expression severely perturbs homeostasis

  2024cites this paper
• Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study

  2024cites this paper
• Sugar signals pedal the cell cycle!

  2024cites this paper
• eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

  2024cites this paper
• SLC25A46 is in contact with lysosomes and plays a role in mitochondrial cholesterol homeostasis

  2024cites this paper
• The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb

  2024cites this paper
• Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.

  2024cites this paper
• ZNL0325, a Pyrazolopyrimidine-Based Covalent Probe, Demonstrates an Alternative Binding Mode for Kinases.

  2024cites this paper
• Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis

  2024cites this paper
• MYC the oncogene from hell: Novel opportunities for cancer therapy.

  2024cites this paper
• Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function

  2024cites this paper
• Disruption of Autophagic Flux and Treatment with the PDPK1 Inhibitor GSK2334470 Synergistically Inhibit Renal Cell Carcinoma Pathogenesis

  2024cites this paper
• Triple coding in human SRD5A1 mRNA

  2024cites this paper
• NaP-TRAP reveals the regulatory grammar in 5’UTR-mediated translation regulation during zebrafish development

  2024cites this paper
• Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives

  2024cites this paper
• A Dual-Target and Dual-Mechanism Design Strategy by Combining Inhibition and Degradation Together.

  2024cites this paper
• LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation

  2024cites this paper
• mTORC1, the maestro of cell metabolism and growth

  2024cites this paper
• Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer

  2024cites this paper
• Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.

  2024cites this paper
• NRF2 signaling and amino acid metabolism in cancer

  2024cites this paper
• New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3

  2024cites this paper
• Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway.

  2024cites this paper
• Ribosome profiling: a powerful tool in oncological research

  2024cites this paper
• TORquing chromatin: the regulatory role of TOR kinase on chromatin function.

  2024cites this paper
• Synergistic antitumor effects of Phlorizin and Temozolomide in glioblastoma: Mechanistic insights and molecular targeting.

  2024cites this paper
• Microproteins in cancer: identification, biological functions, and clinical implications.

  2024cites this paper
• Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research

  2024cites this paper
• GSK-3 kinase a putative therapeutic target in trypanosomatid parasites

  2024cites this paper
• Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis

  2024cites this paper